【Chris】評論
Ranolazine is a newer antianginal drug that appears to act by reducing a late sodium current (I Na ) that facilitates calcium entry via the sodium-calcium exchanger (see Chapter 13). The resulting reduction in intracellular calcium concentration reduces cardiac contractility and work.